Physician profile
James Gentry
NPI 1912297144
$36,456.19
in general payments reported to CMS, 2019-2025
28 companies · $15K in 2025
The $15K reported for 2025 was more than what 94% of Nuclear Cardiology providers received nationally (typical 2025 total: $434).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29.16 · 2020: $54.85 · 2021: $162 · 2022: $4,753 · 2023: $7,196 · 2024: $9,352 · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $21K · Food and Beverage: $6,086 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,500 · Consulting Fee: $1,388 · Travel and Lodging: $846.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $20,637.00 |
| Food and Beverage | $6,085.84 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,500.00 |
| Consulting Fee | $1,387.50 |
| Travel and Lodging | $846.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $26,988.44 | 2022-2025 | Camzyos, Eliquis |
| Abbott Laboratories | $3,026.49 | 2021-2025 | Triclip, Thoratec Heartmate 3 Lvas Implant Kit, Mitraclip |
| Heartflow, INC. | $1,620.30 | 2022-2025 | Ffrct |
| Edwards Lifesciences Corporation | $659.17 | 2022-2025 | Evoque |
| Pfizer INC. | $615.87 | 2020-2025 | |
| Boston Scientific Corporation | $613.84 | 2022-2025 | Accolade Sr, Cds Mct Cem Monitoring Rm, Watchman Flx |
| Amgen INC. | $566.75 | 2021-2025 | Repatha, Repatha |
| Novo Nordisk INC | $356.98 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Janssen Pharmaceuticals, INC | $313.31 | 2022-2024 | Xarelto |
| Lantheus Medical Imaging, INC. | $232.61 | 2021-2025 | Definity |
| Kiniksa Pharmaceuticals International, Plc | $222.57 | 2024 | Arcalyst |
| Boehringer Ingelheim Pharmaceuticals, INC. | $217.56 | 2022-2025 | Jardiance |
| Philips North America LLC | $181.38 | 2022-2025 | Ecc Solutions, (Ck4) Mcot, Mcot |
| Astrazeneca Pharmaceuticals LP | $146.04 | 2022-2024 | Farxiga, Wainua |
| Kiniksa Pharmaceuticals, LTD. | $114.59 | 2023 | Arcalyst |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $79.40 | 2019-2025 | Lifevest |
| Terumo Medical Corporation | $70.30 | 2023-2025 | Azur Cx Detachable, Glidewire, Heartrail |
| Inspire Medical Systems, INC. | $64.08 | 2023-2024 | Inspire |
| Vital Connect, INC | $61.65 | 2022-2023 | Vitalpatch Rtm |
| Bayer Healthcare Pharmaceuticals INC. | $57.43 | 2025 | |
| Becton, Dickinson and Company | $39.28 | 2024 | Hemosphere |
| Cardiva Medical, INC. | $38.51 | 2024 | Other, Optowire |
| Medtronic Vascular, INC. | $34.95 | 2020 | |
| Astellas Pharma US INC | $34.26 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $31.87 | 2022-2025 | |
| Bridgebio Pharma, INC. | $28.77 | 2025 | Attruby |
| Daiichi Sankyo INC. | $23.14 | 2024 | Injectafer |
| Sanofi-Aventis U.S. LLC | $16.65 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Gentry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.